| Literature DB >> 33991181 |
Inmaculada Gómez-Carrascosa1, María L Sánchez-Ferrer1,2, Julian J Arense-Gonzalo2,3, María T Prieto-Sánchez1,2, Emilia Alfosea-Marhuenda1, Miguel A Iniesta1, Jaime Mendiola2,3, Alberto M Torres-Cantero2,3,4,5.
Abstract
AIM: The objective of this study was to evaluate associations between maternal concentrations of 25-hydroxyvitamin D (25(OHD)) and birth outcomes: mode of delivery and episiotomy rate. DESIGN AND METHODS: One hundred and seventeen pregnant women were enrolled in an observational, longitudinal, prospective cohort study. Multivariable linear regression analyses were performed to assess relationships between maternal 25(OHD) concentrations and mode of delivery. To account for systematic temporal variation in 25(OHD), a cosinor model to the data was fitted.Entities:
Keywords: 25-hydroxyvitamin D; caesarean section; episiotomy; instrumented delivery; pregnancy
Mesh:
Substances:
Year: 2021 PMID: 33991181 PMCID: PMC8510719 DOI: 10.1002/nop2.915
Source DB: PubMed Journal: Nurs Open ISSN: 2054-1058
Summary of publications on human studies discussed in the current article
| Study design | Country |
| Gestational age at Vitamin D assay (weeks) | Main outcomes | Statistics | Authors | Quality of evidence (GRADE system) |
|---|---|---|---|---|---|---|---|
| Study cohort | USA (Boston) | 253 | At delivery | C‐section |
| Merewood et al. ( | Low |
| Study cohort | USA | 1,153 | 13 | C‐section |
| Scholl et al. ( | Moderate |
| Retrospective cohort study | UK | 995 | 11–13 | C‐section |
| Savvidou et al. ( | Moderate |
| Case–control | India | 46–46 | At delivery | C‐section | OR 2.31 (0.77–6.92) | Tian et al. ( | Moderate |
| Prospective cohort study (INMA cohort) | Spain | 2,382 | 13.5 | GDM, PTL, C‐section, FGR, SGA, HC, BW |
| Rodriguez et al. ( | High |
| Cohort study | Singapore | 940 | 26–28 | GDM, C‐section | OR 1.39 (0.95–2.05) | Loy et al. ( | Moderate |
| Cohort study | USA | 2,798 | <26 | C‐section, prolonged labour and vaginal instrumentation | RR 0.78 (0.37–1.64) | Gernand et al. ( | Moderate |
| Cohort study | Turkey | 229 | 13 | C‐section |
| Ates et al. (2016) | Low |
| Cohort study | China | 1924 | 12–26 | C‐section |
| Yuan et al. ( | Moderate |
| Cross sectional | Iraq | 100 | 37–42 | C‐section |
| Humadi Al‐Maini (2019) | Low |
Abbreviations: BW, birthweight; C‐section, Caesarean section; FGR, foetal growth rate; GDM, gestational diabetes mellitus; HC, head circumference; PTL, preterm labour; SGA, small for gestational age. The p‐values that are statistically significant are in bold, that is, when the p‐value is less than or equal to 0.005.
FIGURE 1Flow diagram of the study
Characteristics of participants according to quartiles of maternal circulating 25(OHD) concentration in pregnancy
|
| <Q1 | Q1–Q2 | Q2–Q3 | >Q3 |
| |
|---|---|---|---|---|---|---|
| Vitamin D (ng/ml) | 21.58 (7.29) | ≤22 | 22–29 | 29–37 | >37 | |
| Age (years) | 32.6 (4.7) | 31.9 (5.0) | 32.5 (5.1) | 33.1 (4.6) | 32.7 (4.4) | 0.734 |
| BMI at 12 weeks (kg/m2) | 26.3 (5.5) | 24.8 (4.3) | 24.2 (4.3) | 23.9 (3.7) | 0.075 | |
| Underweight: BMI <18.5 | 3 | |||||
| Normal weight: BMI 18.5–25 | 54 | |||||
| Overweight: BMI 25–30 | 29.6 | |||||
| Obese: BMI >30 | 13.4 | |||||
| Parity (1 or more) | 63 | 43.9 | 48.6 | 31.7 | 43.6 | 0.475 |
| Smoking during pregnancy | 12.3 | 25.0 | 5.0 | 7.0 | 10.0 | |
| Alcohol consumption | 2.5 | 0 | 7 | 0 | 0 | |
| Pregestational diabetes mellitus | 1 | 25.0 | 0.5 | 0 | ||
| Season at blood extraction | ||||||
| Winter | 24.4 | 24.3 | 20.9 | 7.3 |
| |
| Spring | 56.1 | 29.7 | 34.9 | 29.3 | ||
| Summer | 14.6 | 21.6 | 11.6 | 17.1 | ||
| Autumn | 4.9 | 24.3 | 32.6 | 46.3 | ||
| Total vigorous MET‐min/week | 84.3 (358.7) | 435.4 (1193.6) | 200.9 (630.5) | 76.1 (388.6) | 0.110 | |
| Total walking MET‐min/week | 733.4 (813.7) | 950.8 (1161.3) | 917.7 (1193.5) | 914.7 (1202.2) | 0.829 | |
| TOTAL, METS/min/week | 1073.9 (1564.7) | 1977.1 (3050.4) | 1255.6 (1927.3) | 1053.6 (1577.1) | 0.227 | |
| Sitting total min/week | 2727.4 (1349.8) | 2.240 (1302.7) | 2375.9 (1415.8) | 2147.3 (1030.4) | 0.218 | |
| Mode of delivery | ||||||
| Eutocic delivery | 51 | |||||
| Instrumental delivery | 22 | |||||
| Caesarean delivery | 27 | |||||
| Primary Caesarean section | 7.5 | |||||
| Newborn gender (females) | 63.2 | 51.4 | 47.6 | 51.3 | 0.542 | |
| Gestational age at birth | 39.0 (1.7) | 38.8 (2.9) | 39.0 (1.6) | 39.2 (1.6) | 0.838 | |
| Birthweight percentile | 52.4 (27.4) | 53 (25.6) | 54.5 (25.7) | 59.4 (25.9) | 0.663 |
Values are percentages for categorical variables and mean (SD) for continuous variables. The p‐values that are statistically significant are in bold, that is, when the p‐value is less than or equal to 0.005.
Adjusted associations of maternal 25(OH)D concentration in pregnancy (ng/ml) with end of delivery
| 25(OHD) (ng/ml) |
| Instrumental | Caesarean (primary cause) | Caesarean (other causes) | ||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |||
| As continuous | 117 | 1.05 [0.97, 1.13] | 0.236 | 0.99 [0.88, 1.11] | 0.835 | 1.04 [0.95, 1.14] | 0.358 | |
| Quartiles | ||||||||
| Q1: ≤22 | Ref | ‐ | Ref | ‐ | Ref | ‐ | ||
| Q2: 22–29 | 1.63 [0.34, 7.73] | 0.541 | 0.68 [0.08, 5.80] | 0.725 | 2.67 [0.35, 20.54] | 0.345 | ||
| Q3: 29–37 | 1.16 [0.29, 4.63] | 0.829 | 0.25 [0.02, 2.77] | 0.257 | 1.15 [0.18, 7.27] | 0.882 | ||
| Q4: >37 | 2.14 [0.50, 9.17] | 0.307 | 1.30 [0.21, 8.08] | 0.781 | 2.50 [0.41, 15.16] | 0.319 | ||
| Clinical cut‐offs | ||||||||
| Deficiency | <20 | 48 (41.0) | Ref | ‐ | Ref | ‐ | Ref | ‐ |
| Insufficiency | 20–29 | 55 (47.0) | 0.99 [0.33, 2.94] | 0.980 | 0.54 [0.12, 2.48] | 0.428 | 1.00 [0.24, 4.07] | 0.995 |
| Sufficiency | ≥30 | 14 (12.0) | 2.54 [0.53, 12.16] | 0.244 | 0.49 [0.03, 7.69] | 0.609 | 2.34 [0.34, 16.05] | 0.387 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Reference: Eutocic delivery (excluding instrumental)
All models adjusted for child's sex, gestational age, parity, age at delivery, maternal overweight and TOTAL METS.
Deseasonalized maternal 25(OHD)D concentration based on month of blood collection for each subject derived from the sinusoidal model.
Adjusted association of maternal concentration of 25‐hydroxyvitamin D (ng/ml) in pregnancy with the incidence of episiotomy
| 25(OHD) (ng/ml) | Episiotomy | |||
|---|---|---|---|---|
|
| OR (95% CI) |
| ||
| As continuous | 117 | 1.01 [0.95, 1.08] | .680 | |
| Quartiless | ||||
| Q1: ≤22 | 29 (24.8) | Ref | ‐ | |
| Q2: 22–29 | 26 (22.2) | 0.88 [0.26, 2.96] | .833 | |
| Q3: 29–37 | 34 (29.1) | 0.72 [0.18, 2.93] | .646 | |
| Q4: >37 | 28 (23.9) | 0.79 [0.24, 2.62] | .695 | |
| Clinical cut‐offs | ||||
| Deficiency | <20 | 48 (41.0) | Ref | ‐ |
| Insufficiency | 20–29 | 55 (47.0) | 0.42 [0.11, 1.63] | .211 |
| Sufficiency | ≥30 | 14 (12.0) | 0.36 [0.09, 1.37] | .133 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Deseasonalized maternal 25(OHD)D concentration based on month of blood collection for each subject derived from the sinusoidal model.